Apatinib for the Treatment of Pulmonary Epithelioid Hemangioendothelioma: A Case Report and Literature Review

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2017 Nov 16

PMID 29137048

Citations 11

Authors

Zhipeng Zheng

Hanying Wang

Hanliang Jiang

Enguo Chen

Jun Zhang

Xinyou Xie

Affiliations

Soon will be listed here.

Abstract

Rationale: Pulmonary epithelioid hemangioendothelioma (P-EHE) is a rare tumor, with no established standard treatment. Overexpression of vascular endothelial growth factor receptor 2 (VEGFR-2) has been reported in some P-EHE patients. Apatinib, a new small molecule tyrosine kinase inhibitor that specifically targets VEGFR-2, has therapeutic benefits in some advanced tumors. However, its efficacy in P-EHE cases has not been reported.

Patient Concerns: Herein, we presented a 44-year-old man with recurrent hemoptysis for approximately 9 years.

Diagnoses: After hospitalization, relevant examinations were conducted. The disease was subsequently diagnosed as P-EHE.

Interventions: The patient underwent pulmonary lobectomy, but subsequently developed multiple metastases. Within the tumor, CD31, CK, and Vimentin were found to be positive, while CD34 was negative. Apatinib was initially administered 250 mg daily doses and after 1 month was increased to 500 mg daily.

Outcomes: He showed noticeable symptomatic improvements and positive imaging changes in the first month of treatment. However, the disease progressed in the following month, despite the increased apatinib dose.

Lessons: Apatinib is possibly a new treatment for P-EHE. However, further clinical trials are necessary to confirm an effective dose and the efficacy and safety of apatinib in P-EHE treatment.

Citing Articles

Isolated pulmonary epithelioid hemangioendothelioma: A case report.

Xuan R, Cui Z, Zhao L Medicine (Baltimore). 2025; 103(52):e40959.

PMID: 39969379 PMC: 11688065. DOI: 10.1097/MD.0000000000040959.

Auricular epithelioid hemangioendothelioma: Two cases first diagnosed as auricular pseudocyst.

Wang Y, Niu Y, Mi Z, Zhao J, Zhang R, Liu J Oncol Lett. 2024; 29(1):17.

PMID: 39492927 PMC: 11529376. DOI: 10.3892/ol.2024.14763.

Primary pulmonary epithelioid hemangioendothelioma.

Jang Y, Hung W, Su T, Wu W BMJ Case Rep. 2023; 16(9).

PMID: 37709495 PMC: 10503352. DOI: 10.1136/bcr-2023-254915.

Primary malignant epithelioid hemangioendothelioma of the pleura: A review and report of a novel case.

Rezvani A, Shahriarirad R, Erfani A, Ranjbar K Clin Case Rep. 2022; 10(8):e6211.

PMID: 35979384 PMC: 9366930. DOI: 10.1002/ccr3.6211.

Malignant Vascular Tumors of the Head and Neck-Which Type of Therapy Works Best?.

Wiegand S, Dietz A, Wichmann G Cancers (Basel). 2021; 13(24).

PMID: 34944821 PMC: 8699575. DOI: 10.3390/cancers13246201.

References

Ouadnouni Y, Bouchikh M, Achir A, Zouaidia F, Smahi M, Msougar Y . Pulmonary epithelioid hemangioendothelioma: a case report. Cases J. 2009; 2:8235. PMC: 2769418. DOI: 10.4076/1757-1626-2-8235. View

Haro A, Saitoh G, Tamiya S, Nagashima A . Four-year natural clinical course of pulmonary epithelioid hemangioendothelioma without therapy. Thorac Cancer. 2015; 6(4):544-7. PMC: 4511336. DOI: 10.1111/1759-7714.12192. View

Watanabe S, Yano F, Kita T, Soga S, Shinmoto H, Kosuda S . 18F-FDG-PET/CT as an indicator for resection of pulmonary epithelioid hemangioendothelioma. Ann Nucl Med. 2008; 22(6):521-4. DOI: 10.1007/s12149-007-0159-z. View

Calabrese C, Gilli M, Rosa N, Di Crescenzo V, Zeppa P, Vitale C . Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma. Open Med (Wars). 2017; 11(1):158-162. PMC: 5329812. DOI: 10.1515/med-2016-0025. View

Adamane S, Deodhar K, Gupta A, Karimundackal G, Desai S . Pulmonary hemangioendothelioma with osteoclast-like giant cells: A rare observation. Indian J Pathol Microbiol. 2016; 59(3):398-400. DOI: 10.4103/0377-4929.188125. View

Sakata K, Gotway M, Smith M, Parish J, Agrwal N, Karlin N . Pulmonary Epithelioid Hemangioendothelioma Diagnosed With Endobronchial Biopsies: A Case Report and Literature Review. J Bronchology Interv Pulmonol. 2016; 23(2):168-73. DOI: 10.1097/LBR.0000000000000230. View

Ross G, Violi L, Friedman A, Edmonds P, Unger E . Intravascular bronchioloalveolar tumor: CT and pathologic correlation. J Comput Assist Tomogr. 1989; 13(2):240-3. DOI: 10.1097/00004728-198903000-00009. View

Soo C, Ng B, Tan E, Hamid F . Ambiguous presentations of pulmonary epithelioid hemangioendothelioma: Two case reports of a rare pulmonary malignancy. SAGE Open Med Case Rep. 2016; 4:2050313X16650323. PMC: 4927211. DOI: 10.1177/2050313X16650323. View

Mizuno Y, Iwata H, Shirahashi K, Hirose Y, Takemura H . Pulmonary epithelioid hemangioendothelioma. Gen Thorac Cardiovasc Surg. 2011; 59(4):297-300. DOI: 10.1007/s11748-010-0651-6. View

10.

Miettinen M, Collan Y, Halttunen P, MAAMIES T, Vilkko P . Intravascular bronchioloalveolar tumor. Cancer. 1987; 60(10):2471-5. DOI: 10.1002/1097-0142(19871115)60:10<2471::aid-cncr2820601021>3.0.co;2-8. View

11.

Bhargava P, Robinson M . Development of second-generation VEGFR tyrosine kinase inhibitors: current status. Curr Oncol Rep. 2011; 13(2):103-11. PMC: 3047052. DOI: 10.1007/s11912-011-0154-3. View

12.

Sangro B, Inarrairaegui M, Fernandez-Ros N . Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib. Rare Tumors. 2012; 4(2):e34. PMC: 3401162. DOI: 10.4081/rt.2012.e34. View

13.

Gaur S, Torabi A, ONeill T . Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report. Cancer Biol Med. 2013; 9(2):133-6. PMC: 3643649. DOI: 10.3969/j.issn.2095-3941.2012.02.010. View

14.

Ye B, Li W, Liu X, Sun K, Yang L, Ma K . Multiple organ metastases of Pulmonary Epithelioid Haemangioendothelioma and a review of the literature. Med Oncol. 2009; 27(1):49-54. DOI: 10.1007/s12032-009-9169-0. View

15.

Li J, Qin S, Xu J, Xiong J, Wu C, Bai Y . Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. J Clin Oncol. 2016; 34(13):1448-54. DOI: 10.1200/JCO.2015.63.5995. View

16.

Weiss S, ENZINGER F . Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982; 50(5):970-81. DOI: 10.1002/1097-0142(19820901)50:5<970::aid-cncr2820500527>3.0.co;2-z. View

17.

Zhang H . Apatinib for molecular targeted therapy in tumor. Drug Des Devel Ther. 2015; 9:6075-81. PMC: 4654530. DOI: 10.2147/DDDT.S97235. View

18.

Amin R, Hiroshima K, Kokubo T, Nishikawa M, Narita M, Kuroki M . Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report. Respirology. 2006; 11(6):818-25. DOI: 10.1111/j.1440-1843.2006.00923.x. View

19.

Tochigi N, Tsuta K, Maeshima A, Shibuki Y, Asamura H, Hasegawa T . Malignant pulmonary epithelioid hemangioendothelioma with hilar lymph node metastasis. Ann Diagn Pathol. 2010; 15(3):207-12. DOI: 10.1016/j.anndiagpath.2010.02.012. View

20.

Tan G, Takano A, Cheah F, Quek R, Koh M . A 58-year-old Woman with Dry Cough and Pulmonary Nodules. Ann Acad Med Singap. 2014; 43(1):59-61. View